Development and validation of discriminating method of dissolution for fosamprenavir tablets based on in vivo data.
about
Development and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension.In vitro-in vivo correlations: general concepts, methodologies and regulatory applications.In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.Buccoadhesive films for once-a-day administration of rivastigmine: systematic formulation development and pharmacokinetic evaluation.Evaluating bioequivalence of meloxicam tablets: is in-vitro dissolution test overdiscriminating?
P2860
Development and validation of discriminating method of dissolution for fosamprenavir tablets based on in vivo data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development and validation of ...... tablets based on in vivo data.
@ast
Development and validation of ...... tablets based on in vivo data.
@en
type
label
Development and validation of ...... tablets based on in vivo data.
@ast
Development and validation of ...... tablets based on in vivo data.
@en
prefLabel
Development and validation of ...... tablets based on in vivo data.
@ast
Development and validation of ...... tablets based on in vivo data.
@en
P2093
P1476
Development and validation of ...... tablets based on in vivo data
@en
P2093
Carolina L Dias
Lisiane Bajerski
Pedro E Fröehlich
Rochele C Rossi
P304
P356
10.1016/J.JPBA.2010.09.004
P577
2010-09-15T00:00:00Z